TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 110 filers reported holding TRANSMEDICS GROUP INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,669,000 | -34.2% | 1,710,851 | +1.0% | 0.12% | -27.6% |
| Q2 2023 | $142,276,000 | +7.6% | 1,694,166 | -2.9% | 0.16% | +3.8% |
| Q1 2023 | $132,176,000 | +10.0% | 1,745,357 | -10.4% | 0.16% | +10.6% |
| Q4 2022 | $120,198,000 | +64.5% | 1,947,472 | +11.3% | 0.14% | +57.8% |
| Q3 2022 | $73,053,000 | +27.3% | 1,750,199 | -4.1% | 0.09% | +40.6% |
| Q2 2022 | $57,391,000 | +2.6% | 1,824,835 | -12.1% | 0.06% | +48.8% |
| Q1 2022 | $55,947,000 | +76.8% | 2,076,736 | +25.8% | 0.04% | +65.4% |
| Q4 2021 | $31,639,000 | -41.1% | 1,651,286 | +1.7% | 0.03% | -43.5% |
| Q3 2021 | $53,745,000 | +6.6% | 1,624,216 | +6.9% | 0.05% | +12.2% |
| Q2 2021 | $50,404,000 | +25.4% | 1,519,121 | +56.9% | 0.04% | -28.1% |
| Q1 2021 | $40,183,000 | +110.1% | 968,494 | +0.8% | 0.06% | +103.6% |
| Q4 2020 | $19,125,000 | +86.3% | 961,073 | +29.0% | 0.03% | +64.7% |
| Q3 2020 | $10,264,000 | +49.3% | 744,861 | +94.1% | 0.02% | +41.7% |
| Q2 2020 | $6,876,000 | – | 383,751 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Must Asset Management Inc. | 94,202 | $5,168,863 | 12.65% |
| Eagle Health Investments LP | 414,205 | $22,677,724 | 5.00% |
| Ophir Asset Management Pty Ltd | 295,761 | $16,192,915 | 3.82% |
| Sandhill Capital Partners LLC | 732,610 | $40,110,409 | 3.75% |
| First Light Asset Management, LLC | 618,100 | $33,840,975 | 3.21% |
| NEXT CENTURY GROWTH INVESTORS LLC | 477,482 | $26,142,139 | 2.84% |
| Bullseye Asset Management LLC | 70,512 | $3,861 | 2.15% |
| Kent Lake Capital LLC | 100,000 | $5,475,000 | 2.10% |
| Nicholas Investment Partners, LP | 413,714 | $22,650,842 | 1.69% |
| AtonRa Partners | 12,287 | $672,713 | 1.41% |